Cargando…
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target
Glycogen synthase kinase 3 (GSK3) is a key regulator of many cellular signaling processes and performs a wide range of biological functions in the nervous system. Due to its central role in numerous cellular processes involved in cell degeneration, a rising number of studies have highlighted the int...
Autores principales: | Hottin, Catherine, Perron, Muriel, Roger, Jérôme E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496697/ https://www.ncbi.nlm.nih.gov/pubmed/36139472 http://dx.doi.org/10.3390/cells11182898 |
Ejemplares similares
-
Glycogen Synthase Kinase 3 Regulates the Genesis of Displaced Retinal Ganglion Cells3
por: Kisseleff, Elena, et al.
Publicado: (2021) -
Targeting Necroptosis: A Novel Therapeutic Option for Retinal Degenerative Diseases
por: Zhang, Qi, et al.
Publicado: (2023) -
Lithium and Therapeutic Targeting of GSK-3
por: Snitow, Melinda E., et al.
Publicado: (2021) -
Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous System
por: Capani, Francisco, et al.
Publicado: (2016) -
Retinal Degeneration Triggers the Activation of YAP/TEAD in Reactive Müller Cells
por: Hamon, Annaïg, et al.
Publicado: (2017)